Ascend Capital’s Dermira, Inc. DERM Stock Holding History

Ascend Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-337,887	Closed	-$9.85M	–	212
2017 Q2	$9.85M	Buy	+337,887	New	+$10.3M	0.46%	74

Other funds holding DERM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ascend Capital's DERM Position: Q3 2017 in Review

Ascend Capital sold out of Dermira, Inc. (DERM) in Q3 2017, closing a stake of 337,887 shares — an estimated $9.85M sold.

Ascend Capital first reported a position in DERM in Q2 2017 and held it in 1 quarter. The position peaked at $9.85M in Q2 2017. 123 funds tracked by Wall St. Rank hold DERM as of Q3 2017.

Ascend Capital reported no remaining Dermira, Inc. position as of Q3 2017 after selling out during the quarter.
Ascend Capital sold 337,887 Dermira, Inc. shares in Q3 2017, an estimated $9.85M.
Ascend Capital first reported a position in Dermira, Inc. in Q2 2017 and held it in 1 quarter.
Ascend Capital's Dermira, Inc. position peaked at $9.85M in Q2 2017.
123 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2017.

Based on Ascend Capital's 13F filing for Q3 2017, filed 13 Nov 2017.